Published in Medical Letter on the CDC and FDA, September 27th, 2009
"This is exciting news for the medical community and patients in Japan," said Catherine Burzik, KCI president and CEO. "Our vision is to transform wound care in Japan by delivering advanced healing solutions and clinical know-how in a way that produces unparalleled outcomes."
The company anticipates that in October the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA